Thyrotoxic Encephalopathy With Seronegative Thyroiditis: An Unusual Occurrence
Abstract
Thyrotoxic encephalopathy is a rare phenomenon that is associated with autoimmune thyroid disorders (Hashimoto's thyroiditis or Graves' disease), where elevated levels of antithyroid antibodies with an excellent response to steroids are seen. Here, we describe a case of thyrotoxic encephalopathy due to seronegative thyroiditis. There are no reports of encephalopathy occurring in a patient with thyrotoxicosis in the absence of thyroid antibodies in the English literature. A 50-year-old woman who was admitted with fever and subclinical hyperthyroidism with negative antibodies progressed over a period of 10 days to develop acute confusion and frank hyperthyroidism. Treatment was started with carbimazole; however, following negative antibodies and imaging studies in keeping with thyroiditis, carbimazole was stopped. Her symptoms worsened, and thyroid function tests continue to show hyperthyroidism. She was extensively investigated for encephalopathy by a multidisciplinary team comprising an endocrinologist, a neurologist, and an infectious diseases team, and neurological causes were comprehensively ruled out. She was restarted on carbimazole, and over the next seven days, her confusion settled, and she returned to her baseline functioning. A diagnosis of thyrotoxicosis secondary to seronegative thyroiditis was made. Over the subsequent few weeks, carbimazole was withdrawn, and she was started on levothyroxine. She continued to make good progress. We present the first case of…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.